APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical Impurity Analysis Service

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pharmaceutical Impurity Analysis Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

1 January 2026191 pages

Choose your research edition.

Industry ResearchPharmaceutical Impurity Analysis Service Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical Impurity Analysis Service Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Pharmaceutical Impurity Analysis Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical Impurity Analysis Service Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical Impurity Analysis Service Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Pharmaceutical Impurity Analysis Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Pharmaceutical Impurity Analysis Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharmaceutical Impurity Analysis Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmaceutical Impurity Analysis Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pharmaceutical Impurity Analysis Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pharmaceutical Impurity Analysis Service include Intertek, Creative Proteomics, Emery Pharma, Agilent, Vimta, Alfa Chemistry, Eurofins, Alera Labs and Impact Analytical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Pharmaceutical Impurity Analysis Service market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmaceutical Impurity Analysis Service and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmaceutical Impurity Analysis Service revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Pharmaceutical Impurity Analysis Service market size, projected growth trends, production technologies, key applications, and end-use industries.

Pharmaceutical Impurity Analysis Service Segment by Company

Intertek

Creative Proteomics

Emery Pharma

Agilent

Vimta

Alfa Chemistry

Eurofins

Alera Labs

Impact Analytical

Leeder Analytical

Nelson Labs

Reading Scientific Services

Regis Technologies

Selvita

SGS

Pharmaceutical Impurity Analysis Service Segment by Type

Organic Impurity Analysis

Inorganic Impurity Analysis

Residual Solvent Analysis

Others

Pharmaceutical Impurity Analysis Service Segment by Application

Pharmaceutical Industry

Agriculture

Biotechnology

Others

Pharmaceutical Impurity Analysis Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Impurity Analysis Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Impurity Analysis Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Impurity Analysis Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Pharmaceutical Impurity Analysis Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmaceutical Impurity Analysis Service industry.

Chapter 3: Detailed analysis of Pharmaceutical Impurity Analysis Service companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceutical Impurity Analysis Servicerevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pharmaceutical Impurity Analysis Service Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Organic Impurity Analysis Table 3. Key Players of Inorganic Impurity Analysis Table 4. Key Players of Residual Solvent Analysis Table 3. Key Players of Others Table 4. Global Pharmaceutical Impurity Analysis Service Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Pharmaceutical Industry Table 6. Key Players of Agriculture Table 7. Key Players of Biotechnology Table 8. Key Players of Others Table 9. Global Pharmaceutical Impurity Analysis Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Pharmaceutical Impurity Analysis Service Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Pharmaceutical Impurity Analysis Service Market Share by Region (2021-2026) Table 12. Global Pharmaceutical Impurity Analysis Service Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Pharmaceutical Impurity Analysis Service Market Share by Region (2027-2032) Table 14. Pharmaceutical Impurity Analysis Service Industry Trends Table 15. Pharmaceutical Impurity Analysis Service Industry Drivers Table 16. Pharmaceutical Impurity Analysis Service Industry Opportunities and Challenges Table 17. Pharmaceutical Impurity Analysis Service Industry Restraints Table 18. Global Pharmaceutical Impurity Analysis Service Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Pharmaceutical Impurity Analysis Service Revenue Market Share by Company (2021-2026) Table 20. Global Pharmaceutical Impurity Analysis Service Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Pharmaceutical Impurity Analysis Service Key Company Head Office and Area Served Table 22. Global Pharmaceutical Impurity Analysis Service Company, Product Type & Application Table 23. Global Pharmaceutical Impurity Analysis Service Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Pharmaceutical Impurity Analysis Service by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Pharmaceutical Impurity Analysis Service Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Pharmaceutical Impurity Analysis Service Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Pharmaceutical Impurity Analysis Service Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Pharmaceutical Impurity Analysis Service Revenue Market Share by Type (2021-2026) Table 30. Global Pharmaceutical Impurity Analysis Service Revenue Market Share by Type (2027-2032) Table 31. Global Pharmaceutical Impurity Analysis Service Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Pharmaceutical Impurity Analysis Service Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Pharmaceutical Impurity Analysis Service Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Pharmaceutical Impurity Analysis Service Revenue Market Share by Application (2021-2026) Table 35. Global Pharmaceutical Impurity Analysis Service Revenue Market Share by Application (2027-2032) Table 36. Intertek Company Information Table 37. Intertek Business Overview Table 38. Intertek Pharmaceutical Impurity Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Intertek Pharmaceutical Impurity Analysis Service Product Portfolio Table 40. Intertek Recent Development Table 41. Creative Proteomics Company Information Table 42. Creative Proteomics Business Overview Table 43. Creative Proteomics Pharmaceutical Impurity Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Creative Proteomics Pharmaceutical Impurity Analysis Service Product Portfolio Table 45. Creative Proteomics Recent Development Table 46. Emery Pharma Company Information Table 47. Emery Pharma Business Overview Table 48. Emery Pharma Pharmaceutical Impurity Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Emery Pharma Pharmaceutical Impurity Analysis Service Product Portfolio Table 50. Emery Pharma Recent Development Table 51. Agilent Company Information Table 52. Agilent Business Overview Table 53. Agilent Pharmaceutical Impurity Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Agilent Pharmaceutical Impurity Analysis Service Product Portfolio Table 55. Agilent Recent Development Table 56. Vimta Company Information Table 57. Vimta Business Overview Table 58. Vimta Pharmaceutical Impurity Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Vimta Pharmaceutical Impurity Analysis Service Product Portfolio Table 60. Vimta Recent Development Table 61. Alfa Chemistry Company Information Table 62. Alfa Chemistry Business Overview Table 63. Alfa Chemistry Pharmaceutical Impurity Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Alfa Chemistry Pharmaceutical Impurity Analysis Service Product Portfolio Table 65. Alfa Chemistry Recent Development Table 66. Eurofins Company Information Table 67. Eurofins Business Overview Table 68. Eurofins Pharmaceutical Impurity Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Eurofins Pharmaceutical Impurity Analysis Service Product Portfolio Table 70. Eurofins Recent Development Table 71. Alera Labs Company Information Table 72. Alera Labs Business Overview Table 73. Alera Labs Pharmaceutical Impurity Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Alera Labs Pharmaceutical Impurity Analysis Service Product Portfolio Table 75. Alera Labs Recent Development Table 76. Impact Analytical Company Information Table 77. Impact Analytical Business Overview Table 78. Impact Analytical Pharmaceutical Impurity Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Impact Analytical Pharmaceutical Impurity Analysis Service Product Portfolio Table 80. Impact Analytical Recent Development Table 81. Leeder Analytical Company Information Table 82. Leeder Analytical Business Overview Table 83. Leeder Analytical Pharmaceutical Impurity Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Leeder Analytical Pharmaceutical Impurity Analysis Service Product Portfolio Table 85. Leeder Analytical Recent Development Table 86. Nelson Labs Company Information Table 87. Nelson Labs Business Overview Table 88. Nelson Labs Pharmaceutical Impurity Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. Nelson Labs Pharmaceutical Impurity Analysis Service Product Portfolio Table 90. Nelson Labs Recent Development Table 91. Reading Scientific Services Company Information Table 92. Reading Scientific Services Business Overview Table 93. Reading Scientific Services Pharmaceutical Impurity Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 94. Reading Scientific Services Pharmaceutical Impurity Analysis Service Product Portfolio Table 95. Reading Scientific Services Recent Development Table 96. Regis Technologies Company Information Table 97. Regis Technologies Business Overview Table 98. Regis Technologies Pharmaceutical Impurity Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 99. Regis Technologies Pharmaceutical Impurity Analysis Service Product Portfolio Table 100. Regis Technologies Recent Development Table 101. Selvita Company Information Table 102. Selvita Business Overview Table 103. Selvita Pharmaceutical Impurity Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 104. Selvita Pharmaceutical Impurity Analysis Service Product Portfolio Table 105. Selvita Recent Development Table 106. SGS Company Information Table 107. SGS Business Overview Table 108. SGS Pharmaceutical Impurity Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 109. SGS Pharmaceutical Impurity Analysis Service Product Portfolio Table 110. SGS Recent Development Table 111. North America Pharmaceutical Impurity Analysis Service Market Size by Type (2021-2026) & (US$ Million) Table 112. North America Pharmaceutical Impurity Analysis Service Market Size by Type (2027-2032) & (US$ Million) Table 113. North America Pharmaceutical Impurity Analysis Service Market Size by Application (2021-2026) & (US$ Million) Table 114. North America Pharmaceutical Impurity Analysis Service Market Size by Application (2027-2032) & (US$ Million) Table 115. North America Pharmaceutical Impurity Analysis Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. North America Pharmaceutical Impurity Analysis Service Market Size by Country (2021-2026) Table 117. North America Pharmaceutical Impurity Analysis Service Market Size by Country (2027-2032) Table 118. Europe Pharmaceutical Impurity Analysis Service Market Size by Type (2021-2026) & (US$ Million) Table 119. Europe Pharmaceutical Impurity Analysis Service Market Size by Type (2027-2032) & (US$ Million) Table 120. Europe Pharmaceutical Impurity Analysis Service Market Size by Application (2021-2026) & (US$ Million) Table 121. Europe Pharmaceutical Impurity Analysis Service Market Size by Application (2027-2032) & (US$ Million) Table 122. Europe Pharmaceutical Impurity Analysis Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Europe Pharmaceutical Impurity Analysis Service Market Size by Country (2021-2026) Table 124. Europe Pharmaceutical Impurity Analysis Service Market Size by Country (2027-2032) Table 125. China Pharmaceutical Impurity Analysis Service Market Size by Type (2021-2026) & (US$ Million) Table 126. China Pharmaceutical Impurity Analysis Service Market Size by Type (2027-2032) & (US$ Million) Table 127. China Pharmaceutical Impurity Analysis Service Market Size by Application (2021-2026) & (US$ Million) Table 128. China Pharmaceutical Impurity Analysis Service Market Size by Application (2027-2032) & (US$ Million) Table 129. Asia Pharmaceutical Impurity Analysis Service Market Size by Type (2021-2026) & (US$ Million) Table 130. Asia Pharmaceutical Impurity Analysis Service Market Size by Type (2027-2032) & (US$ Million) Table 131. Asia Pharmaceutical Impurity Analysis Service Market Size by Application (2021-2026) & (US$ Million) Table 132. Asia Pharmaceutical Impurity Analysis Service Market Size by Application (2027-2032) & (US$ Million) Table 133. Asia Pharmaceutical Impurity Analysis Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 134. Asia Pharmaceutical Impurity Analysis Service Market Size by Country (2021-2026) Table 135. Asia Pharmaceutical Impurity Analysis Service Market Size by Country (2027-2032) Table 136. South America, Middle East & Africa Pharmaceutical Impurity Analysis Service Market Size by Type (2021-2026) & (US$ Million) Table 137. South America, Middle East & Africa Pharmaceutical Impurity Analysis Service Market Size by Type (2027-2032) & (US$ Million) Table 138. South America, Middle East & Africa Pharmaceutical Impurity Analysis Service Market Size by Application (2021-2026) & (US$ Million) Table 139. South America, Middle East & Africa Pharmaceutical Impurity Analysis Service Market Size by Application (2027-2032) & (US$ Million) Table 140. South America, Middle East & Africa Pharmaceutical Impurity Analysis Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 141. South America, Middle East & Africa Pharmaceutical Impurity Analysis Service Market Size by Country (2021-2026) Table 142. South America, Middle East & Africa Pharmaceutical Impurity Analysis Service Market Size by Country (2027-2032) Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. Pharmaceutical Impurity Analysis Service Product Image Figure 2. Global Pharmaceutical Impurity Analysis Service Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Pharmaceutical Impurity Analysis Service Market Share by Type: 2025 VS 2032 Figure 4. Organic Impurity Analysis Image Figure 5. Inorganic Impurity Analysis Image Figure 6. Residual Solvent Analysis Image Figure 7. Others Image Figure 8. Global Pharmaceutical Impurity Analysis Service Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Pharmaceutical Impurity Analysis Service Market Share by Application: 2025 VS 2032 Figure 10. Pharmaceutical Industry Image Figure 11. Agriculture Image Figure 12. Biotechnology Image Figure 13. Others Image Figure 14. Global Pharmaceutical Impurity Analysis Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Pharmaceutical Impurity Analysis Service Market Size (2021-2032) & (US$ Million) Figure 16. Global Pharmaceutical Impurity Analysis Service Market Share by Region: 2025 VS 2032 Figure 17. Years Considered Figure 18. Global Pharmaceutical Impurity Analysis Service Market Share by Players in 2025 Figure 19. Global Top 5 and 10 Pharmaceutical Impurity Analysis Service Players Market Share by Revenue in 2025 Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Pharmaceutical Impurity Analysis Service Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Pharmaceutical Impurity Analysis Service Revenue Market Share by Type (2021-2032) Figure 23. Global Pharmaceutical Impurity Analysis Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Pharmaceutical Impurity Analysis Service Revenue Market Share by Application (2021-2032) Figure 25. North America Pharmaceutical Impurity Analysis Service Market Size (2021-2032) & (US$ Million) Figure 26. North America Pharmaceutical Impurity Analysis Service Market Share by Type (2021-2032) Figure 27. North America Pharmaceutical Impurity Analysis Service Market Share by Application (2021-2032) Figure 28. North America Pharmaceutical Impurity Analysis Service Market Share by Country (2021-2032) Figure 29. United States Pharmaceutical Impurity Analysis Service Market Size (2021-2032) & (US$ Million) Figure 30. Canada Pharmaceutical Impurity Analysis Service Market Size (2021-2032) & (US$ Million) Figure 31. Mexico Pharmaceutical Impurity Analysis Service Market Size (2021-2032) & (US$ Million) Figure 32. Europe Pharmaceutical Impurity Analysis Service Market Size (2021-2032) & (US$ Million) Figure 33. Europe Pharmaceutical Impurity Analysis Service Market Share by Type (2021-2032) Figure 34. Europe Pharmaceutical Impurity Analysis Service Market Share by Application (2021-2032) Figure 35. Europe Pharmaceutical Impurity Analysis Service Market Share by Country (2021-2032) Figure 36. Germany Pharmaceutical Impurity Analysis Service Market Size (2021-2032) & (US$ Million) Figure 37. France Pharmaceutical Impurity Analysis Service Market Size (2021-2032) & (US$ Million) Figure 38. U.K. Pharmaceutical Impurity Analysis Service Market Size (2021-2032) & (US$ Million) Figure 39. Italy Pharmaceutical Impurity Analysis Service Market Size (2021-2032) & (US$ Million) Figure 40. Russia Pharmaceutical Impurity Analysis Service Market Size (2021-2032) & (US$ Million) Figure 41. Nordic Countries Pharmaceutical Impurity Analysis Service Market Size (2021-2032) & (US$ Million) Figure 42. China Pharmaceutical Impurity Analysis Service Market Size (2021-2032) & (US$ Million) Figure 43. China Pharmaceutical Impurity Analysis Service Market Share by Type (2021-2032) Figure 44. China Pharmaceutical Impurity Analysis Service Market Share by Application (2021-2032) Figure 45. Asia Pharmaceutical Impurity Analysis Service Market Size (2021-2032) & (US$ Million) Figure 46. Asia Pharmaceutical Impurity Analysis Service Market Share by Type (2021-2032) Figure 47. Asia Pharmaceutical Impurity Analysis Service Market Share by Application (2021-2032) Figure 48. Asia Pharmaceutical Impurity Analysis Service Market Share by Country (2021-2032) Figure 49. Japan Pharmaceutical Impurity Analysis Service Market Size (2021-2032) & (US$ Million) Figure 50. South Korea Pharmaceutical Impurity Analysis Service Market Size (2021-2032) & (US$ Million) Figure 51. Taiwan Pharmaceutical Impurity Analysis Service Market Size (2021-2032) & (US$ Million) Figure 52. Southeast Asia Pharmaceutical Impurity Analysis Service Market Size (2021-2032) & (US$ Million) Figure 53. India Pharmaceutical Impurity Analysis Service Market Size (2021-2032) & (US$ Million) Figure 54. Australia Pharmaceutical Impurity Analysis Service Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Pharmaceutical Impurity Analysis Service Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Pharmaceutical Impurity Analysis Service Market Share by Type (2021-2032) Figure 57. South America, Middle East & Africa Pharmaceutical Impurity Analysis Service Market Share by Application (2021-2032) Figure 58. South America, Middle East & Africa Pharmaceutical Impurity Analysis Service Market Share by Country (2021-2032) Figure 59. Brazil Pharmaceutical Impurity Analysis Service Market Size (2021-2032) & (US$ Million) Figure 60. South Africa Pharmaceutical Impurity Analysis Service Market Size (2021-2032) & (US$ Million) Figure 61. Saudi Arabia Pharmaceutical Impurity Analysis Service Market Size (2021-2032) & (US$ Million) Figure 62. Turkey Pharmaceutical Impurity Analysis Service Market Size (2021-2032) & (US$ Million) Figure 63. Argentina Pharmaceutical Impurity Analysis Service Market Size (2021-2032) & (US$ Million) Figure 64. UAE Pharmaceutical Impurity Analysis Service Market Size (2021-2032) & (US$ Million) Figure 65. Egypt Pharmaceutical Impurity Analysis Service Market Size (2021-2032) & (US$ Million) Figure 66. Chile Pharmaceutical Impurity Analysis Service Market Size (2021-2032) & (US$ Million) Figure 67. Research Process Figure 68. Key Executives Interviewed

Scope & coverage.

Types
  • Organic Impurity Analysis
  • Inorganic Impurity Analysis
  • Residual Solvent Analysis
  • Others
Applications
  • Pharmaceutical Industry
  • Agriculture
  • Biotechnology
  • Others
Companies covered
  • Intertek
  • Creative Proteomics
  • Emery Pharma
  • Agilent
  • Vimta
  • Alfa Chemistry
  • Eurofins
  • Alera Labs
  • Impact Analytical
  • Leeder Analytical
  • Nelson Labs
  • Reading Scientific Services
  • Regis Technologies
  • Selvita
  • SGS

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Pharmaceutical Impurity Analysis Service Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Organic Impurity Analysis
  5. 1.2.3 Inorganic Impurity Analysis
  6. 1.2.4 Residual Solvent Analysis
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Pharmaceutical Impurity Analysis Service Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Pharmaceutical Industry
  11. 1.3.3 Agriculture
  12. 1.3.4 Biotechnology
  13. 1.3.5 Others
  14. 1.4 Global Market Growth Prospects
  15. 1.5 Global Pharmaceutical Impurity Analysis Service Growth Trends by Region
  16. 1.5.1 Global Pharmaceutical Impurity Analysis Service Market Size by Region: 2021 VS 2025 VS 2032
  17. 1.5.2 Pharmaceutical Impurity Analysis Service Market Size by Region (2021-2026)
  18. 1.5.3 Pharmaceutical Impurity Analysis Service Market Size by Region (2027-2032)
  19. 1.6 Assumptions and Limitations
  20. 1.7 Study Goals and Objectives
  21. 1.8 Years Considered
2 Global Pharmaceutical Impurity Analysis Service Market Dynamics
  1. 2.1 Pharmaceutical Impurity Analysis Service Industry Trends
  2. 2.2 Pharmaceutical Impurity Analysis Service Industry Drivers
  3. 2.3 Pharmaceutical Impurity Analysis Service Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical Impurity Analysis Service Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Pharmaceutical Impurity Analysis Service Revenue by Company (2021-2026)
  2. 3.2 Global Pharmaceutical Impurity Analysis Service Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Pharmaceutical Impurity Analysis Service Key Company Head office and Area Served
  4. 3.4 Global Pharmaceutical Impurity Analysis Service Company, Product Type & Application
  5. 3.5 Global Pharmaceutical Impurity Analysis Service Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Pharmaceutical Impurity Analysis Service Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Pharmaceutical Impurity Analysis Service Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Pharmaceutical Impurity Analysis Service Tier 1, Tier 2, and Tier 3
4 Pharmaceutical Impurity Analysis Service Market by Type
  1. 4.1 Global Pharmaceutical Impurity Analysis Service Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Pharmaceutical Impurity Analysis Service Market Size by Type (2021-2032)
  3. 4.3 Global Pharmaceutical Impurity Analysis Service Market Size Share by Type (2021-2032)
5 Pharmaceutical Impurity Analysis Service Market by Application
  1. 5.1 Global Pharmaceutical Impurity Analysis Service Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Pharmaceutical Impurity Analysis Service Market Size by Application (2021-2032)
  3. 5.3 Global Pharmaceutical Impurity Analysis Service Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Intertek
  2. 6.1.1 Intertek Company Information
  3. 6.1.2 Intertek Business Overview
  4. 6.1.3 Intertek Pharmaceutical Impurity Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Intertek Pharmaceutical Impurity Analysis Service Product Portfolio
  6. 6.1.5 Intertek Recent Developments
  7. 6.2 Creative Proteomics
  8. 6.2.1 Creative Proteomics Company Information
  9. 6.2.2 Creative Proteomics Business Overview
  10. 6.2.3 Creative Proteomics Pharmaceutical Impurity Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Creative Proteomics Pharmaceutical Impurity Analysis Service Product Portfolio
  12. 6.2.5 Creative Proteomics Recent Developments
  13. 6.3 Emery Pharma
  14. 6.3.1 Emery Pharma Company Information
  15. 6.3.2 Emery Pharma Business Overview
  16. 6.3.3 Emery Pharma Pharmaceutical Impurity Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Emery Pharma Pharmaceutical Impurity Analysis Service Product Portfolio
  18. 6.3.5 Emery Pharma Recent Developments
  19. 6.4 Agilent
  20. 6.4.1 Agilent Company Information
  21. 6.4.2 Agilent Business Overview
  22. 6.4.3 Agilent Pharmaceutical Impurity Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Agilent Pharmaceutical Impurity Analysis Service Product Portfolio
  24. 6.4.5 Agilent Recent Developments
  25. 6.5 Vimta
  26. 6.5.1 Vimta Company Information
  27. 6.5.2 Vimta Business Overview
  28. 6.5.3 Vimta Pharmaceutical Impurity Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Vimta Pharmaceutical Impurity Analysis Service Product Portfolio
  30. 6.5.5 Vimta Recent Developments
  31. 6.6 Alfa Chemistry
  32. 6.6.1 Alfa Chemistry Company Information
  33. 6.6.2 Alfa Chemistry Business Overview
  34. 6.6.3 Alfa Chemistry Pharmaceutical Impurity Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Alfa Chemistry Pharmaceutical Impurity Analysis Service Product Portfolio
  36. 6.6.5 Alfa Chemistry Recent Developments
  37. 6.7 Eurofins
  38. 6.7.1 Eurofins Company Information
  39. 6.7.2 Eurofins Business Overview
  40. 6.7.3 Eurofins Pharmaceutical Impurity Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Eurofins Pharmaceutical Impurity Analysis Service Product Portfolio
  42. 6.7.5 Eurofins Recent Developments
  43. 6.8 Alera Labs
  44. 6.8.1 Alera Labs Company Information
  45. 6.8.2 Alera Labs Business Overview
  46. 6.8.3 Alera Labs Pharmaceutical Impurity Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Alera Labs Pharmaceutical Impurity Analysis Service Product Portfolio
  48. 6.8.5 Alera Labs Recent Developments
  49. 6.9 Impact Analytical
  50. 6.9.1 Impact Analytical Company Information
  51. 6.9.2 Impact Analytical Business Overview
  52. 6.9.3 Impact Analytical Pharmaceutical Impurity Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Impact Analytical Pharmaceutical Impurity Analysis Service Product Portfolio
  54. 6.9.5 Impact Analytical Recent Developments
  55. 6.10 Leeder Analytical
  56. 6.10.1 Leeder Analytical Company Information
  57. 6.10.2 Leeder Analytical Business Overview
  58. 6.10.3 Leeder Analytical Pharmaceutical Impurity Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Leeder Analytical Pharmaceutical Impurity Analysis Service Product Portfolio
  60. 6.10.5 Leeder Analytical Recent Developments
  61. 6.11 Nelson Labs
  62. 6.11.1 Nelson Labs Company Information
  63. 6.11.2 Nelson Labs Business Overview
  64. 6.11.3 Nelson Labs Pharmaceutical Impurity Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Nelson Labs Pharmaceutical Impurity Analysis Service Product Portfolio
  66. 6.11.5 Nelson Labs Recent Developments
  67. 6.12 Reading Scientific Services
  68. 6.12.1 Reading Scientific Services Company Information
  69. 6.12.2 Reading Scientific Services Business Overview
  70. 6.12.3 Reading Scientific Services Pharmaceutical Impurity Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Reading Scientific Services Pharmaceutical Impurity Analysis Service Product Portfolio
  72. 6.12.5 Reading Scientific Services Recent Developments
  73. 6.13 Regis Technologies
  74. 6.13.1 Regis Technologies Company Information
  75. 6.13.2 Regis Technologies Business Overview
  76. 6.13.3 Regis Technologies Pharmaceutical Impurity Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Regis Technologies Pharmaceutical Impurity Analysis Service Product Portfolio
  78. 6.13.5 Regis Technologies Recent Developments
  79. 6.14 Selvita
  80. 6.14.1 Selvita Company Information
  81. 6.14.2 Selvita Business Overview
  82. 6.14.3 Selvita Pharmaceutical Impurity Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Selvita Pharmaceutical Impurity Analysis Service Product Portfolio
  84. 6.14.5 Selvita Recent Developments
  85. 6.15 SGS
  86. 6.15.1 SGS Company Information
  87. 6.15.2 SGS Business Overview
  88. 6.15.3 SGS Pharmaceutical Impurity Analysis Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 SGS Pharmaceutical Impurity Analysis Service Product Portfolio
  90. 6.15.5 SGS Recent Developments
7 North America
  1. 7.1 North America Pharmaceutical Impurity Analysis Service Market Size (2021-2032)
  2. 7.2 North America Pharmaceutical Impurity Analysis Service Market Size by Type
  3. 7.2.1 North America Pharmaceutical Impurity Analysis Service Market Size by Type (2021-2026)
  4. 7.2.2 North America Pharmaceutical Impurity Analysis Service Market Size by Type (2027-2032)
  5. 7.2.3 North America Pharmaceutical Impurity Analysis Service Market Share by Type (2021-2032)
  6. 7.3 North America Pharmaceutical Impurity Analysis Service Market Size by Application
  7. 7.3.1 North America Pharmaceutical Impurity Analysis Service Market Size by Application (2021-2026)
  8. 7.3.2 North America Pharmaceutical Impurity Analysis Service Market Size by Application (2027-2032)
  9. 7.3.3 North America Pharmaceutical Impurity Analysis Service Market Share by Application (2021-2032)
  10. 7.4 North America Pharmaceutical Impurity Analysis Service Market Size by Country
  11. 7.4.1 North America Pharmaceutical Impurity Analysis Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Pharmaceutical Impurity Analysis Service Market Size by Country (2021-2026)
  13. 7.4.3 North America Pharmaceutical Impurity Analysis Service Market Size by Country (2027-2032)
  14. 7.4.4 North America Pharmaceutical Impurity Analysis Service Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Pharmaceutical Impurity Analysis Service Market Size (2021-2032)
  2. 8.2 Europe Pharmaceutical Impurity Analysis Service Market Size by Type
  3. 8.2.1 Europe Pharmaceutical Impurity Analysis Service Market Size by Type (2021-2026)
  4. 8.2.2 Europe Pharmaceutical Impurity Analysis Service Market Size by Type (2027-2032)
  5. 8.2.3 Europe Pharmaceutical Impurity Analysis Service Market Share by Type (2021-2032)
  6. 8.3 Europe Pharmaceutical Impurity Analysis Service Market Size by Application
  7. 8.3.1 Europe Pharmaceutical Impurity Analysis Service Market Size by Application (2021-2026)
  8. 8.3.2 Europe Pharmaceutical Impurity Analysis Service Market Size by Application (2027-2032)
  9. 8.3.3 Europe Pharmaceutical Impurity Analysis Service Market Share by Application (2021-2032)
  10. 8.4 Europe Pharmaceutical Impurity Analysis Service Market Size by Country
  11. 8.4.1 Europe Pharmaceutical Impurity Analysis Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Pharmaceutical Impurity Analysis Service Market Size by Country (2021-2026)
  13. 8.4.3 Europe Pharmaceutical Impurity Analysis Service Market Size by Country (2027-2032)
  14. 8.4.4 Europe Pharmaceutical Impurity Analysis Service Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Pharmaceutical Impurity Analysis Service Market Size (2021-2032)
  2. 9.2 China Pharmaceutical Impurity Analysis Service Market Size by Type
  3. 9.2.1 China Pharmaceutical Impurity Analysis Service Market Size by Type (2021-2026)
  4. 9.2.2 China Pharmaceutical Impurity Analysis Service Market Size by Type (2027-2032)
  5. 9.2.3 China Pharmaceutical Impurity Analysis Service Market Share by Type (2021-2032)
  6. 9.3 China Pharmaceutical Impurity Analysis Service Market Size by Application
  7. 9.3.1 China Pharmaceutical Impurity Analysis Service Market Size by Application (2021-2026)
  8. 9.3.2 China Pharmaceutical Impurity Analysis Service Market Size by Application (2027-2032)
  9. 9.3.3 China Pharmaceutical Impurity Analysis Service Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Pharmaceutical Impurity Analysis Service Market Size (2021-2032)
  2. 10.2 Asia Pharmaceutical Impurity Analysis Service Market Size by Type
  3. 10.2.1 Asia Pharmaceutical Impurity Analysis Service Market Size by Type (2021-2026)
  4. 10.2.2 Asia Pharmaceutical Impurity Analysis Service Market Size by Type (2027-2032)
  5. 10.2.3 Asia Pharmaceutical Impurity Analysis Service Market Share by Type (2021-2032)
  6. 10.3 Asia Pharmaceutical Impurity Analysis Service Market Size by Application
  7. 10.3.1 Asia Pharmaceutical Impurity Analysis Service Market Size by Application (2021-2026)
  8. 10.3.2 Asia Pharmaceutical Impurity Analysis Service Market Size by Application (2027-2032)
  9. 10.3.3 Asia Pharmaceutical Impurity Analysis Service Market Share by Application (2021-2032)
  10. 10.4 Asia Pharmaceutical Impurity Analysis Service Market Size by Country
  11. 10.4.1 Asia Pharmaceutical Impurity Analysis Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Pharmaceutical Impurity Analysis Service Market Size by Country (2021-2026)
  13. 10.4.3 Asia Pharmaceutical Impurity Analysis Service Market Size by Country (2027-2032)
  14. 10.4.4 Asia Pharmaceutical Impurity Analysis Service Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Pharmaceutical Impurity Analysis Service Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Pharmaceutical Impurity Analysis Service Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Pharmaceutical Impurity Analysis Service Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Pharmaceutical Impurity Analysis Service Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Pharmaceutical Impurity Analysis Service Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Pharmaceutical Impurity Analysis Service Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Pharmaceutical Impurity Analysis Service Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Pharmaceutical Impurity Analysis Service Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Pharmaceutical Impurity Analysis Service Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Pharmaceutical Impurity Analysis Service Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Pharmaceutical Impurity Analysis Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Pharmaceutical Impurity Analysis Service Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Pharmaceutical Impurity Analysis Service Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Pharmaceutical Impurity Analysis Service Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst